| Financial Year |
March 31 2023 |
| Monetary Funds |
1,706,989,250.77 |
| Held-for-trading Financial Assets |
143,836,168.79 |
| Notes Receivable |
1,472,787,498.17 |
| Accounts Receivable |
2,842,320,721.70 |
| Advances to Suppliers |
108,034,487.59 |
| Other Receivables |
40,417,166.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,574,066,458.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
45,507,968.46 |
| Total Current Assets |
8,370,210,841.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
407,150,931.45 |
| Investment Properties |
-- |
| Fixed Assetes |
1,400,663,384.77 |
| Under-construction Projects |
89,025,385.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
274,903,496.32 |
| R&D expenses |
-- |
| Goodwill |
97,443,652.95 |
| Long-Term Deferred and Prepaid Expenses |
4,397,597.06 |
| Deferred Income Tax Assets |
75,895,524.48 |
| Other Non-Current Assets |
156,725,333.27 |
| Sub-Total of Non-Current Assets |
2,729,496,746.28 |
| Total Assets |
11,099,707,587.71 |
| Short-Term Loans |
2,711,279,230.23 |
| Trading Financial liabilities |
268,250.00 |
| Notes Payable |
957,950,000.00 |
| Accounts Payable |
495,115,157.32 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
111,424,326.66 |
| Taxes Payable |
43,765,205.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
49,121,774.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
29,125,161.60 |
| Other Current Liabilities |
465,724,005.01 |
| Sub-Total of Current Liabilities |
4,902,734,123.93 |
| Long-term Loans |
340,933,004.92 |
| Bonds Payable |
465,805,633.86 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
27,635,263.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
934,172,768.65 |
| Total Liabilities |
5,836,906,892.58 |
| Paid-In Capital(Or Share Stock) |
2,079,138,085.00 |
| Capital Surplus |
406,547,226.61 |
| Surplus Reserve |
156,569,423.34 |
| LESS:Treasury Stock |
110,068,275.82 |
| Undistributed Profits |
2,466,859,572.33 |
| Minority Stockholder's Interest |
111,092,493.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,151,708,201.52 |
| Owner's Equity（Stockholder's Equity） |
5,262,800,695.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,099,707,587.71 |
